Walleye Capital
LLY icon

Walleye Capital’s Eli Lilly LLY Stock Holding History

Walleye Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.36M Sell
7,800
-1,000
-11% -$1.02M 0.03% 507
2026
Q1 		$8.09M Sell
8,800
-4,100
-32% -$4.16M 0.03% 508
2025
Q4 		$13.9M Sell
12,900
-17,100
-57% -$16.4M 0.04% 453
2025
Q3 		$22.9M Buy
30,000
+3,900
+15% +$2.9M 0.09% 213
2025
Q2 		$20.3M Buy
26,100
+5,000
+24% +$3.89M 0.08% 225
2025
Q1 		$17.4M Sell
21,100
-49,400
-70% -$41.1M 0.08% 240
2024
Q4 		$54.4M Sell
70,500
-2,700
-4% -$2.24M 0.13% 99
2024
Q3 		$64.9M Sell
73,200
-4,800
-6% -$4.32M 0.13% 82
2024
Q2 		$70.6M Sell
78,000
-17,900
-19% -$14.3M 0.13% 84
2024
Q1 		$74.6M Buy
95,900
+16,500
+21% +$11.7M 0.13% 85
2023
Q4 		$46.3M Sell
79,400
-2,900
-4% -$1.69M 0.1% 117
2023
Q3 		$44.2M Buy
82,300
+33,700
+69% +$17.4M 0.11% 94
2023
Q2 		$22.8M Buy
48,600
+45,200
+1,329% +$19M 0.08% 135
2023
Q1 		$1.17M Sell
3,400
-4,500
-57% -$1.52M 0.02% 1051
2022
Q4 		$2.89M Sell
7,900
-2,800
-26% -$993K 0.05% 428
2022
Q3 		$3.46M Buy
+10,700
New +$3.39M 0.07% 317
2020
Q2 		– Sell
-2,400
Closed -$333K – 810
2020
Q1 		$333K Sell
2,400
-3,700
-61% -$508K 0.07% 314
2019
Q4 		$802K Sell
6,100
-5,200
-46% -$603K 0.05% 492
2019
Q3 		$1.26M Sell
11,300
-1,000
-8% -$111K 0.08% 362
2019
Q2 		$1.36M Buy
12,300
+1,600
+15% +$188K 0.15% 180
2019
Q1 		$1.39M Buy
+10,700
New +$1.3M 0.23% 96

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Walleye Capital's LLY Position: Q2 2026 in Review

Walleye Capital increased its Eli Lilly (LLY) stake by 38% in Q2 2026, buying an estimated $7.98M and bringing the position to 28,457 shares worth $34.1M. The position accounts for 0.12% of the portfolio, ranked #115.

Walleye Capital first reported a position in LLY in Q1 2019 and has held it in 23 quarters since. The position peaked at $47M in Q3 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Walleye Capital held 28,457 shares of Eli Lilly worth $34.1M as of Q2 2026.
  • Walleye Capital bought 7,813 Eli Lilly shares in Q2 2026, an estimated $7.98M.
  • Eli Lilly made up 0.12% of Walleye Capital's portfolio in Q2 2026, its #115 holding.
  • Walleye Capital first reported a position in Eli Lilly in Q1 2019 and has held it in 23 quarters since.
  • Walleye Capital's Eli Lilly position peaked at $47M in Q3 2024.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.